Mario Delgado Selected Research

(N- Ac- His(1)- Nle(17)- Arg(20,21)- Ala(26))- vasoactive intestinal peptide

11/2007	Emerging roles of vasoactive intestinal peptide: a new approach for autoimmune therapy.
12/2006	A novel mechanism for immunosuppression: from neuropeptides to regulatory T cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mario Delgado Research Topics

Disease

28	Inflammation (Inflammations) 01/2022 - 08/2002
23	Autoimmune Diseases (Autoimmune Disease) 01/2017 - 01/2002
15	Rheumatoid Arthritis 01/2017 - 01/2003
11	Immune System Diseases (Immune Disorders) 09/2015 - 06/2007
11	Experimental Arthritis 01/2015 - 03/2006
10	Arthritis (Polyarthritis) 01/2017 - 05/2003
9	Colitis 01/2022 - 04/2003
9	Multiple Sclerosis 11/2021 - 05/2003
7	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 11/2021 - 09/2005
7	Crohn Disease (Crohn's Disease) 03/2009 - 04/2003
7	Septic Shock (Toxic Shock Syndrome) 01/2007 - 01/2002
6	Sepsis (Septicemia) 09/2015 - 09/2006
6	Parkinson Disease (Parkinson's Disease) 01/2013 - 05/2003
5	Fibrosis (Cirrhosis) 01/2022 - 01/2002
5	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021 - 03/2006
5	Graft vs Host Disease (Graft-Versus-Host Disease) 05/2009 - 05/2006
4	Pain (Aches) 06/2021 - 05/2013
4	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2018 - 01/2003
4	Weight Loss (Weight Reduction) 02/2018 - 04/2003
3	Hyperalgesia 06/2021 - 05/2013
3	Atherosclerotic Plaque (Atheroma) 01/2018 - 05/2013
3	Alzheimer Disease (Alzheimer's Disease) 01/2013 - 10/2003
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2007 - 05/2003
3	Leukemia 12/2006 - 05/2006
3	Diarrhea 12/2006 - 03/2006
3	Peritonitis 01/2002 - 01/2002
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022 - 11/2021
2	Huntington Disease (Huntington's Disease) 11/2021 - 02/2018
2	Cardiomegaly (Heart Hypertrophy) 01/2018 - 01/2017
2	Atherosclerosis 01/2018 - 01/2017
2	Myocarditis (Carditis) 01/2018 - 01/2017
2	Vascular Calcification 01/2017 - 05/2013
2	Neoplasms (Cancer) 09/2008 - 05/2006
2	Hypersensitivity (Allergy) 07/2006 - 12/2005
2	Endotoxemia 06/2006 - 03/2006
2	Body Weight (Weight, Body) 05/2006 - 03/2006
2	Shock 10/2003 - 01/2002
1	Nervous System Diseases (Neurological Disorders) 01/2022
1	Systemic Scleroderma (Systemic Sclerosis) 01/2022
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022
1	Pathologic Processes 01/2022
1	Pneumonia (Pneumonitis) 11/2021
1	Respiratory Insufficiency (Respiratory Failure) 11/2021
1	Neuralgia (Stump Neuralgia) 06/2021
1	Diabetic Neuropathies (Diabetic Neuropathy) 06/2021
1	Peripheral Nerve Injuries 06/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020

Drug/Important Bio-Agent (IBA)

29	NeuropeptidesIBA 01/2022 - 01/2002
23	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 01/2018 - 04/2003
22	Therapeutic UsesIBA 01/2018 - 04/2003
17	CytokinesIBA 11/2021 - 01/2002
16	cortistatinIBA 01/2022 - 03/2006
8	Peptides (Polypeptides)IBA 06/2021 - 03/2006
8	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 01/2007 - 01/2002
6	Pharmaceutical PreparationsIBA 11/2021 - 07/2006
6	Sulfonic AcidsIBA 01/2017 - 04/2003
5	AntigensIBA 03/2009 - 03/2006
4	Interleukin-6 (Interleukin 6)IBA 11/2021 - 01/2002
4	Ghrelin ReceptorsIBA 11/2021 - 05/2007
4	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 11/2021 - 05/2007
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2013 - 01/2002
3	EndotoxinsIBA 11/2021 - 03/2006
3	Analgesics (Analgesic Drugs)IBA 06/2021 - 05/2013
3	Proteins (Proteins, Gene)FDA Link 10/2010 - 10/2007
3	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 11/2008 - 01/2002
3	UrocortinsIBA 05/2008 - 06/2006
3	ChemokinesIBA 04/2008 - 01/2002
3	Neuroprotective AgentsIBA 10/2005 - 05/2003
2	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022 - 11/2021
2	3-nitropropionic acidIBA 11/2021 - 02/2018
2	ApolipoproteinsIBA 01/2018 - 01/2017
2	Collagen Type II (Type II Collagen)IBA 01/2017 - 01/2015
2	sym-trinitrobenzeneIBA 01/2017 - 01/2014
2	LipidsIBA 01/2017 - 10/2008
2	Dextran SulfateIBA 01/2017 - 01/2014
2	Interleukin-10 (Interleukin 10)IBA 08/2013 - 02/2007
2	GhrelinIBA 06/2008 - 05/2006
2	HMGB1 Protein (HMG1)IBA 06/2008 - 05/2008
2	DNA (Deoxyribonucleic Acid)IBA 05/2008 - 07/2006
2	(N- Ac- His(1)- Nle(17)- Arg(20,21)- Ala(26))- vasoactive intestinal peptideIBA 11/2007 - 12/2006
2	cortistatin AIBA 05/2007 - 03/2006
2	AdrenomedullinIBA 01/2007 - 06/2006
2	Immunomodulating AgentsIBA 06/2006 - 03/2006
2	AlbuminsIBA 01/2005 - 01/2002
2	Interleukin-12 (IL 12)IBA 01/2003 - 01/2002
1	AP 1903 reagentIBA 01/2022
1	Conditioned Culture MediaIBA 01/2022
1	3- (5- nitrofuryl)- 7- (5- nitrofurfurylidene)- 3,3a,4,5,6,7- hexahydro- 2H- indazoleIBA 11/2021
1	Chimeric Antigen ReceptorsIBA 01/2020
1	ResveratrolIBA 02/2018
1	ProdrugsIBA 02/2018

Therapy/Procedure

19	Therapeutics 01/2022 - 01/2002
7	Ligation 01/2022 - 03/2006
5	Punctures 08/2013 - 03/2006
3	Bone Marrow Transplantation (Transplantation, Bone Marrow) 12/2006 - 05/2006
3	Continuous Ambulatory Peritoneal Dialysis (CAPD) 01/2002 - 01/2002
2	Homologous Transplantation 05/2009 - 05/2006
2	Transplantation 09/2007 - 06/2007
1	Drug Therapy (Chemotherapy) 01/2022
1	Intradermal Injections 01/2022